Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors

H.M.W. Verheul, B. Salumbides, K. van Erp, H. Hammers, D.Z. Qian, T. Sanni, P. Atadja, R. Pili

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{c47c41644ad84a4c999a6a1c43bd539a,

title = "Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors",

author = "H.M.W. Verheul and B. Salumbides and {van Erp}, K. and H. Hammers and D.Z. Qian and T. Sanni and P. Atadja and R. Pili",

year = "2008",

doi = "10.1158/1078-0432.CCR-07-4306",

language = "Undefined/Unknown",

volume = "14",

pages = "3589--3597",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

TY - JOUR

T1 - Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors

AU - Verheul, H.M.W.

AU - Salumbides, B.

AU - van Erp, K.

AU - Hammers, H.

AU - Qian, D.Z.

AU - Sanni, T.

AU - Atadja, P.

AU - Pili, R.

PY - 2008

Y1 - 2008

U2 - 10.1158/1078-0432.CCR-07-4306

DO - 10.1158/1078-0432.CCR-07-4306

M3 - Article

C2 - 18519793

VL - 14

SP - 3589

EP - 3597

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11

ER -